iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/24345640
Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jan:53:108-23.
doi: 10.1016/j.plipres.2013.11.003. Epub 2013 Dec 15.

Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer

Guodong Zhang  1 , Sean Kodani  2 , Bruce D Hammock  3
Affiliations
Review

Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer

Guodong Zhang et al. Prog Lipid Res. 2014 Jan.

Abstract

Epoxygenated fatty acids (EpFAs), which are lipid mediators produced by cytochrome P450 epoxygenases from polyunsaturated fatty acids, are important signaling molecules known to regulate various biological processes including inflammation, pain and angiogenesis. The EpFAs are further metabolized by soluble epoxide hydrolase (sEH) to form fatty acid diols which are usually less-active. Pharmacological inhibitors of sEH that stabilize endogenous EpFAs are being considered for human clinical uses. Here we review the biology of ω-3 and ω-6 EpFAs on inflammation, pain, angiogenesis and tumorigenesis.

Keywords: Cytochrome P450 epoxygenase; Epoxydocosapentaenoic acids; Epoxyeicosatrienoic acids; Soluble epoxide hydrolase.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The metabolism of arachidonic acid by cytochrome P450 (CYP) epoxygenases (largely CYP2C and CYP2J) leads to the formation of epoxyeicosatrienoic acids (EETs) including four regioisomers of 5,6-, 8,9-, 11,12- and 14,15-EET. EETs are further metabolized by soluble epoxide hydrolase (sEH) to form the fatty acid diols termed dihydroxyeicosatrienoic acids (DHETs) which are usually less-active or inactive.
Fig. 2
Fig. 2
The ω-3 PUFAs including EPA and DHA are highly efficient alternative substrates of the CYP/sEH pathway. The metabolism of EPA and DHA by CYP epoxygenases generates ω-3-series epoxygenated fatty acids (EpFAs), including 5 regioisomers of EEQs from EPA and 6 EDP isomers from DHA. Compared with ARA, EPA and DHA showed higher or similar activities toward the metabolism by CYP epoxygenases. Compared with EETs, EEQs and EDPs are also better substrates of sEH to be metabolized to the corresponding fatty acid diols (DiHETE and DiHDPA respectively) with the exception of 19,20-EDP.
Fig. 3
Fig. 3
Genetic deletion or pharmacological inhibition of sEH in ω-6-rich and ω-3-rich tissues leads to accumulation of EETs and EDPs respectively, leading to different effects on angiogenesis.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Buczynski MW, Dumlao DS, Dennis EA. Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology. J Lipid Res. 2009;50:1015–38. - PMC - PubMed
    1. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001;294:1871–5. - PubMed
    1. Zeldin DC. Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem. 2001;276:36059–62. - PubMed
    1. Imig JD, Hammock BD. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discov. 2009;8:794–805. - PMC - PubMed
    1. Morisseau C, Hammock BD. Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health. Annu Rev Pharmacol Toxicol. 2013;53:37–58. - PMC - PubMed

Publication types